Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 15, 2008 Filed Oct 16, 2008 19:29 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionStock Option · Derivative | 2,400 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-08-000078 · edgar.xml · derivative · entry 6 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Underlying: Common Stock · 2,400 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| October 15, 2008 Filed Oct 16, 2008 19:29 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 480 | $27.74 | $13,315.20 |
DisclosureSEC source: 0000875320-08-000078 · edgar.xml · nonDerivative · entry 4 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,390 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F4 · price: Open market sales reported on this line occurred at a weighted average price of $27.74 (range $27.61 to $27.87). F5 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2008 Filed Oct 16, 2008 19:29 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 1,200 | $26.84 | $32,208.00 |
DisclosureSEC source: 0000875320-08-000078 · edgar.xml · nonDerivative · entry 3 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,870 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $26.84 (range $26.44 to $27.36). F5 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2008 Filed Oct 16, 2008 19:29 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 720 | $25.73 | $18,525.60 |
DisclosureSEC source: 0000875320-08-000078 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,070 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $25.73 (range $25.35 to $26.18). F5 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2008 Filed Oct 16, 2008 19:29 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionCommon Stock | 2,400 | $9.07 | $21,768.00 |
DisclosureSEC source: 0000875320-08-000078 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2008 Filed Oct 23, 2008 18:12 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 7,400 | $23.79 | $176,046.00 |
DisclosureSEC source: 0000875320-08-000080 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $23.79 (range $23.50 to $24.23). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2008 Filed Oct 2, 2008 15:02 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionStock Option · Derivative | 4,253 | $0.00 Strike: $13.63 | $0.00 |
DisclosureSEC source: 0000875320-08-000076 · edgar.xml · derivative · entry 4 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,761 Underlying: Common Stock · 4,253 shares Expires 2008-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| October 01, 2008 Filed Oct 2, 2008 15:02 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
SaleCommon Stock | 4,253 | $32.65 | $138,860.45 |
DisclosureSEC source: 0000875320-08-000076 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,792 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $32.65 (range $32.30 to $33.08). F3 · price: Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2008 Filed Oct 2, 2008 15:02 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionCommon Stock | 4,253 | $13.63 | $57,968.39 |
DisclosureSEC source: 0000875320-08-000076 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2008 Filed Sep 19, 2008 15:31 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionStock Option · Derivative | 2,400 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-08-000074 · edgar.xml · derivative · entry 4 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Underlying: Common Stock · 2,400 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| September 17, 2008 Filed Sep 19, 2008 15:31 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 2,400 | $27.94 | $67,056.00 |
DisclosureSEC source: 0000875320-08-000074 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,390 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $27.94 (range $27.46 to $28.40). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2008 Filed Sep 19, 2008 15:31 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionCommon Stock | 2,400 | $9.07 | $21,768.00 |
DisclosureSEC source: 0000875320-08-000074 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2008 Filed Sep 11, 2008 20:24 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionStock Option · Derivative | 6,614 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000072 · edgar.xml · derivative · entry 4 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,614 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| September 10, 2008 Filed Sep 11, 2008 20:24 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
SaleCommon Stock | 6,614 | $26.23 | $173,485.22 |
DisclosureSEC source: 0000875320-08-000072 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,792 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $26.34 (range $26.02 to $26.42). F3 · price: Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| September 10, 2008 Filed Sep 11, 2008 20:24 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionCommon Stock | 6,614 | $10.19 | $67,396.66 |
DisclosureSEC source: 0000875320-08-000072 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2008 Filed Sep 11, 2008 20:25 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 12,778 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000073 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,778 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| September 10, 2008 Filed Sep 11, 2008 20:25 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 3,678 | $26.86 | $98,791.08 |
DisclosureSEC source: 0000875320-08-000073 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $26.86 (range $26.59 to $27.00). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| September 10, 2008 Filed Sep 11, 2008 20:25 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 9,100 | $26.23 | $238,693.00 |
DisclosureSEC source: 0000875320-08-000073 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098,722 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $26.23 (range $25.56 to $26.49). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| September 10, 2008 Filed Sep 11, 2008 20:25 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,778 | $10.19 | $130,207.82 |
DisclosureSEC source: 0000875320-08-000073 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2008 Filed Sep 4, 2008 19:33 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 12,400 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000070 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,778 Underlying: Common Stock · 12,400 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| September 03, 2008 Filed Sep 4, 2008 19:33 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 12,400 | $25.93 | $321,532.00 |
DisclosureSEC source: 0000875320-08-000070 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $25.93 (range $25.47 to $26.43). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2008 Filed Sep 4, 2008 19:33 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,400 | $10.19 | $126,356.00 |
DisclosureSEC source: 0000875320-08-000070 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2008 Filed Sep 4, 2008 20:14 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionStock Option · Derivative | 6,612 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000071 · edgar.xml · derivative · entry 4 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,614 Underlying: Common Stock · 6,612 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| September 03, 2008 Filed Sep 4, 2008 20:14 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
SaleCommon Stock | 6,612 | $25.86 | $170,986.32 |
DisclosureSEC source: 0000875320-08-000071 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,792 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $25.86 (range $25.49 to $26.26). F3 · price: Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2008 Filed Sep 4, 2008 20:14 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionCommon Stock | 6,612 | $10.19 | $67,376.28 |
DisclosureSEC source: 0000875320-08-000071 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2008 Filed Aug 28, 2008 17:17 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 12,400 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000068 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,178 Underlying: Common Stock · 12,400 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| August 27, 2008 Filed Aug 28, 2008 17:17 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 12,400 | $27.03 | $335,172.00 |
DisclosureSEC source: 0000875320-08-000068 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $27.03 (range $26.66 to $27.47). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 27, 2008 Filed Aug 28, 2008 17:17 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,400 | $10.19 | $126,356.00 |
DisclosureSEC source: 0000875320-08-000068 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2008 Filed Aug 28, 2008 17:19 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionStock Option · Derivative | 6,612 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000069 · edgar.xml · derivative · entry 4 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,226 Underlying: Common Stock · 6,612 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 27, 2008 Filed Aug 28, 2008 17:19 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
SaleCommon Stock | 6,612 | $27.02 | $178,656.24 |
DisclosureSEC source: 0000875320-08-000069 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,792 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $27.02 (range $26.70 to $27.47). F3 · price: Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 27, 2008 Filed Aug 28, 2008 17:19 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionCommon Stock | 6,612 | $10.19 | $67,376.28 |
DisclosureSEC source: 0000875320-08-000069 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2008 Filed Aug 21, 2008 17:52 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionStock Option · Derivative | 6,612 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000066 · edgar.xml · derivative · entry 5 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,838 Underlying: Common Stock · 6,612 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| August 20, 2008 Filed Aug 21, 2008 17:52 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
SaleCommon Stock | 1,920 | $27.99 | $53,740.80 |
DisclosureSEC source: 0000875320-08-000066 · edgar.xml · nonDerivative · entry 3 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,792 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on thsi line occurred at a weighted average price of $27.99 (range $27.91 to $28.10). F4 · price: Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 20, 2008 Filed Aug 21, 2008 17:52 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
SaleCommon Stock | 4,692 | $27.40 | $128,560.80 |
DisclosureSEC source: 0000875320-08-000066 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,712 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $27.40 (range $26.96 to $27.78). F4 · price: Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 20, 2008 Filed Aug 21, 2008 17:52 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionCommon Stock | 6,612 | $10.19 | $67,376.28 |
DisclosureSEC source: 0000875320-08-000066 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2008 Filed Aug 21, 2008 17:54 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 12,400 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000067 · edgar.xml · derivative · entry 7 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,578 Underlying: Common Stock · 12,400 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| August 20, 2008 Filed Aug 21, 2008 17:54 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 834 | $28.17 | $23,493.78 |
DisclosureSEC source: 0000875320-08-000067 · edgar.xml · nonDerivative · entry 4 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F4 · price: Open market sales reported on this line occurred at a weighted average price of $28.17 (range $28.06 to $28.33). F5 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 20, 2008 Filed Aug 21, 2008 17:54 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 7,100 | $27.61 | $196,031.00 |
DisclosureSEC source: 0000875320-08-000067 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,878 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $27.61 (range $27.05 to $28.00). F5 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 20, 2008 Filed Aug 21, 2008 17:54 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 4,466 | $26.40 | $117,902.40 |
DisclosureSEC source: 0000875320-08-000067 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,102,978 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $26.40 (range $26.05 to $27.00). F5 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 20, 2008 Filed Aug 21, 2008 17:54 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,400 | $10.19 | $126,356.00 |
DisclosureSEC source: 0000875320-08-000067 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2008 Filed Aug 14, 2008 18:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 12,400 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000065 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,978 Underlying: Common Stock · 12,400 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| August 13, 2008 Filed Aug 14, 2008 18:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 3,000 | $29.75 | $89,250.00 |
DisclosureSEC source: 0000875320-08-000065 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $29.75 (range $29.54 to $30.17). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 13, 2008 Filed Aug 14, 2008 18:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 9,400 | $28.97 | $272,318.00 |
DisclosureSEC source: 0000875320-08-000065 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.97 (range $28.54 to $29.53). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 13, 2008 Filed Aug 14, 2008 18:36 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,400 | $10.19 | $126,356.00 |
DisclosureSEC source: 0000875320-08-000065 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2008 Filed Aug 7, 2008 16:41 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 12,400 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000063 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,378 Underlying: Common Stock · 12,400 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| August 06, 2008 Filed Aug 7, 2008 16:41 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 6,600 | $31.24 | $206,184.00 |
DisclosureSEC source: 0000875320-08-000063 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $31.24 (range $31.00 to $31.91). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2008 Filed Aug 7, 2008 16:41 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 5,800 | $30.62 | $177,596.00 |
DisclosureSEC source: 0000875320-08-000063 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101,644 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $30.62 (range $30.30 to $30.99). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2008 Filed Aug 7, 2008 16:41 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,400 | $10.19 | $126,356.00 |
DisclosureSEC source: 0000875320-08-000063 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2008 Filed Jul 31, 2008 19:16 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionStock Options · Derivative | 12,400 | $0.00 Strike: $10.19 | $0.00 |
DisclosureSEC source: 0000875320-08-000062 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,778 Underlying: Common Stock · 12,400 shares Expires 2008-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| July 30, 2008 Filed Jul 31, 2008 19:16 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 9,816 | $32.91 | $323,044.56 |
DisclosureSEC source: 0000875320-08-000062 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,778 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $32.91 (range $32.59 to $33.25). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.